NYSE:CGCCanopy Growth Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $19.42 +1.17 (+6.41 %) (As of 05/25/2020 04:00 PM ET) Add Compare Share Today's Range$17.60Now: $19.42▼$19.4850-Day Range$13.25MA: $15.19▼$18.2552-Week Range$9.00Now: $19.42▼$45.78Volume14.00 million shsAverage Volume7.31 million shsMarket Capitalization$6.81 billionP/E RatioN/ADividend YieldN/ABeta2.62 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.Read More Beat the Market (BTM) Rank™ 4.2 Analyst's Opinion Consensus RatingCanopy Growth has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 10 buy ratings, 13 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $37.74, Canopy Growth has a potential upside of 94.4% from its current price of $19.42.Amount of Analyst CoverageCanopy Growth has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.6 Community Rank Outperform VotesCanopy Growth has received 633 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCanopy Growth has received 580 “underperform” votes. (Add your “underperform” vote.)Community SentimentCanopy Growth has received 52.18% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote “Outperform” if you believe CGC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCanopy Growth does not currently pay a dividend.Dividend GrowthCanopy Growth does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Canopy Growth insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 10.44% of the stock of Canopy Growth is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Canopy Growth are expected to grow in the coming year, from ($1.63) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Canopy Growth is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Canopy Growth is -4.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCanopy Growth has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.49 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryCannabis SectorMedical Current SymbolNYSE:CGC Previous Symbol CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone855-558-9333Debt Debt-to-Equity Ratio0.10 Current Ratio7.58 Quick Ratio5.96Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$170.25 million Price / Sales40.01 Cash FlowN/A Price / Cash FlowN/A Book Value$16.03 per share Price / Book1.21Profitability EPS (Most Recent Fiscal Year)($1.59) Net Income$-522,300,000.00 Net Margins-535.05% Return on Equity-14.97% Return on Assets-10.81%Miscellaneous Employees3,200 Outstanding Shares350,800,000Market Cap$6.81 billion Next Earnings Date5/29/2020 (Confirmed) OptionableOptionable CGC Rates by TradingView Receive CGC News and Ratings via Email Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Canopy Growth (NYSE:CGC) Frequently Asked Questions How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)? Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CGC stock has increased by 45.5% and is now trading at $19.42. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Canopy Growth? 23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 13 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Canopy Growth. When is Canopy Growth's next earnings date? Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, May 29th 2020. View our earnings forecast for Canopy Growth. How can I listen to Canopy Growth's earnings call? Canopy Growth will be holding an earnings conference call on Friday, May 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. What price target have analysts set for CGC? 23 brokerages have issued 12 month target prices for Canopy Growth's shares. Their forecasts range from $15.60 to $107.57. On average, they anticipate Canopy Growth's stock price to reach $37.74 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price. View analysts' price targets for Canopy Growth. Has Canopy Growth been receiving favorable news coverage? News stories about CGC stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Canopy Growth earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave news articles about the marijuana producer a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutCanopy Growth. Who are some of Canopy Growth's key competitors? Some companies that are related to Canopy Growth include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), OrganiGram (OGI), GrowGeneration (GRWG), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), 22nd Century Group (XXII), KushCo (KSHB), Terra Tech (TRTC), General Cannabis (CANN), mCig (MCIG), Nemus Bioscience (NMUS), Grow Capital (GRWC) and Leafbuyer Technologies (LBUY). View all competitors. What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), KushCo (KSHB) and Aurora Cannabis (ACB). Who are Canopy Growth's key executives? Canopy Growth's management team includes the following people: Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEOMr. Timothy Rob Saunders, Exec. OfficerMr. Rade Kovacevic, Exec. VPMr. Mike Lee, Acting Chief Financial Officer What is Canopy Growth's stock symbol? Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC." Who are Canopy Growth's major shareholders? Canopy Growth's stock is owned by many different retail and institutional investors. Top institutional investors include ETF Managers Group LLC (0.74%), CIBC World Markets Inc. (0.40%), The Manufacturers Life Insurance Company (0.30%), Morgan Stanley (0.28%), Swiss National Bank (0.23%) and Legal & General Group Plc (0.22%). Which institutional investors are selling Canopy Growth stock? CGC stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, ETF Managers Group LLC, Toronto Dominion Bank, Commerzbank Aktiengesellschaft FI, Canada Pension Plan Investment Board, Janus Henderson Group PLC, Cambridge Investment Research Advisors Inc., and Kingsview Wealth Management LLC. Which institutional investors are buying Canopy Growth stock? CGC stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Advisor Group Holdings Inc., Swiss National Bank, V Wealth Advisors LLC, Atom Investors LP, Parametric Portfolio Associates LLC, Valeo Financial Advisors LLC, and Verde Capital Management. How do I buy shares of Canopy Growth? Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Canopy Growth's stock price today? One share of CGC stock can currently be purchased for approximately $19.42. How big of a company is Canopy Growth? Canopy Growth has a market capitalization of $6.81 billion and generates $170.25 million in revenue each year. The marijuana producer earns $-522,300,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. Canopy Growth employs 3,200 workers across the globe. What is Canopy Growth's official website? The official website for Canopy Growth is www.canopygrowth.com. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A 0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected] This page was last updated on 5/25/2020 by MarketBeat.com Staff
